Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Investing

Merck : MRK

All Merck Articles

1086 Articles

Paul Ausick | Jan 27, 2016 at 4:01 PM EST

The 4 Stocks That Tanked the Dow on Wednesday

January 27, 2016: Markets opened lower on Wednesday, but a brief morning sojourn into positive territory only lasted until the…

Jon C. Ogg | Jan 27, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Wednesday's top analyst calls include Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald's, Merck, Newmont Mining and Sprint.

Chris Lange | Jan 25, 2016 at 11:35 AM EST

Could This Merck Deal Be the Turning Point for Affimed?

Affimed shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck.

Jon C. Ogg | Jan 20, 2016 at 7:50 AM EST

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if…

Jon C. Ogg | Jan 13, 2016 at 10:35 AM EST

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

A bull market interrupted is how many investors likely feel at the start of 2016. These are the seven Dow…

Chris Lange | Jan 13, 2016 at 9:15 AM EST

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks…

Lee Jackson | Jan 8, 2016 at 11:05 AM EST

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap…

Chris Lange | Jan 6, 2016 at 10:35 AM EST

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case…

Jon C. Ogg | Jan 4, 2016 at 8:50 AM EST

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Dogs of the Dow is a dividend strategy for investors to buy what are either "cheap" or "beaten up" Dow…

Lee Jackson | Dec 28, 2015 at 10:10 AM EST

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life.…

Chris Lange | Dec 28, 2015 at 9:35 AM EST

Major Pharma Short Interest Takes Another Giant Leap Forward

The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical…

Paul Ausick | Dec 17, 2015 at 4:01 PM EST

The 4 Stocks That Sank the DJIA on Thursday

December 17, 2015: Markets opened higher on Thursday but the end came quickly for the gains. After about half an…

Jon C. Ogg | Dec 15, 2015 at 4:52 PM EST

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a…

Paul Ausick | Dec 10, 2015 at 4:01 PM EST

The 4 Stocks That Lifted the Dow on Thursday

December 10, 2015: Markets opened lower for a fourth consecutive day on Thursday but almost immediately broke into positive territory…

Chris Lange | Dec 10, 2015 at 8:50 AM EST

Short Interest in Major Pharma Takes a Giant Leap

The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

1 … 38 39 40 41 42 … 73

Merck : MRK

All Merck Articles

The 4 Stocks That Tanked the Dow on Wednesday

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Could This Merck Deal Be the Turning Point for Affimed?

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

Major Pharma Short Sellers Increase Bets

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

Major Pharma Short Interest Takes Another Giant Leap Forward

The 4 Stocks That Sank the DJIA on Thursday

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

The 4 Stocks That Lifted the Dow on Thursday

Short Interest in Major Pharma Takes a Giant Leap

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

QQQI Holders Left $7.63 Per Share on the Table While Chasing Monthly Dividends

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

Merck : MRK

All Merck Articles

The 4 Stocks That Tanked the Dow on Wednesday

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Could This Merck Deal Be the Turning Point for Affimed?

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

Major Pharma Short Sellers Increase Bets

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

Major Pharma Short Interest Takes Another Giant Leap Forward

The 4 Stocks That Sank the DJIA on Thursday

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

The 4 Stocks That Lifted the Dow on Thursday

Short Interest in Major Pharma Takes a Giant Leap

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

QQQI Holders Left $7.63 Per Share on the Table While Chasing Monthly Dividends

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

Featured Reads

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back